Incidence Rates, Household Infection Risk, and Clinical Characteristics of SARS-CoV-2 Infection Among Children and Adults in Utah and New York City, New York.


Journal

JAMA pediatrics
ISSN: 2168-6211
Titre abrégé: JAMA Pediatr
Pays: United States
ID NLM: 101589544

Informations de publication

Date de publication:
01 01 2022
Historique:
pubmed: 9 10 2021
medline: 20 1 2022
entrez: 8 10 2021
Statut: ppublish

Résumé

Data about the risk of SARS-CoV-2 infection among children compared with adults are needed to inform COVID-19 risk communication and prevention strategies, including COVID-19 vaccination policies for children. To compare incidence rates and clinical characteristics of SARS-CoV-2 infection among adults and children and estimated household infection risks within a prospective household cohort. Households with at least 1 child aged 0 to 17 years in selected counties in Utah and New York City, New York, were eligible for enrollment. From September 2020 through April 2021, participants self-collected midturbinate nasal swabs for reverse transcription-polymerase chain reaction testing for SARS-CoV-2 and responded to symptom questionnaires each week. Participants also self-collected additional respiratory specimens with onset of COVID-19-like illness. For children unable to self-collect respiratory specimens, an adult caregiver collected the specimens. The primary outcome was incident cases of any SARS-CoV-2 infection, including asymptomatic and symptomatic infections. Additional measures were the asymptomatic fraction of infection calculated by dividing incidence rates of asymptomatic infection by rates of any infection, clinical characteristics of infection, and household infection risks. Primary outcomes were compared by participant age group. A total of 1236 participants in 310 households participated in surveillance, including 176 participants (14%) who were aged 0 to 4 years, 313 (25%) aged 5 to 11 years, 163 (13%) aged 12 to 17 years, and 584 (47%) 18 years or older. Overall incidence rates of SARS-CoV-2 infection were 3.8 (95% CI, 2.4-5.9) and 7.7 (95% CI, 4.1-14.5) per 1000 person-weeks among the Utah and New York City cohorts, respectively. Site-adjusted incidence rates per 1000 person-weeks were similar by age group: 6.3 (95% CI, 3.6-11.0) for children 0 to 4 years, 4.4 (95% CI, 2.5-7.5) for children 5 to 11 years, 6.0 (95% CI, 3.0-11.7) for children 12 to 17 years, and 5.1 (95% CI, 3.3-7.8) for adults (≥18 years). The asymptomatic fractions of infection by age group were 52%, 50%, 45%, and 12% among individuals aged 0 to 4 years, 5 to 11 years, 12 to 17 years, and 18 years or older, respectively. Among 40 households with 1 or more SARS-CoV-2 infections, the mean risk of SARS-CoV-2 infection among all enrolled household members was 52% (range, 11%-100%), with higher risks in New York City compared with Utah (80% [95% CI, 64%-91%] vs 44% [95% CI, 36%-53%]; P < .001). In this study, children had similar incidence rates of SARS-CoV-2 infection compared with adults, but a larger proportion of infections among children were asymptomatic.

Identifiants

pubmed: 34623377
pii: 2785007
doi: 10.1001/jamapediatrics.2021.4217
pmc: PMC8501415
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-67

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States

Commentaires et corrections

Type : CommentIn

Auteurs

Fatimah S Dawood (FS)

Centers for Disease Control and Prevention, Atlanta, Georgia.

Christina A Porucznik (CA)

Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City.

Vic Veguilla (V)

Centers for Disease Control and Prevention, Atlanta, Georgia.

Joseph B Stanford (JB)

Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City.

Jazmin Duque (J)

Abt Associates, Atlanta, Georgia.

Melissa A Rolfes (MA)

Centers for Disease Control and Prevention, Atlanta, Georgia.

Ashton Dixon (A)

Centers for Disease Control and Prevention, Atlanta, Georgia.

Priyam Thind (P)

Division of Child and Adolescent Health, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York.

Emily Hacker (E)

Division of Public Health, Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City.

Maria Julia E Castro (MJE)

Division of Child and Adolescent Health, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York.

Zuha Jeddy (Z)

Abt Associates, Atlanta, Georgia.

Michael Daugherty (M)

Centers for Disease Control and Prevention, Atlanta, Georgia.

Kim Altunkaynak (K)

Abt Associates, Atlanta, Georgia.

Danielle Rentz Hunt (DR)

Abt Associates, Atlanta, Georgia.

Utsav Kattel (U)

Abt Associates, Atlanta, Georgia.

Jennifer Meece (J)

Marshfield Virology Laboratory, Marshfield, Wisconsin.

Melissa S Stockwell (MS)

Division of Child and Adolescent Health, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York.
Department of Population and Family Health, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York.

Classifications MeSH